CalciMedica (CALC) Total Non-Current Liabilities (2019 - 2026)
CalciMedica's (CALC) quarterly Total Non-Current Liabilities came in at $9.5 million in Q1 2026, down 27.15% YoY from $13.1 million in Q1 2025, and down 22.23% on a QoQ basis from $12.2 million in Q4 2025.
CalciMedica (CALC) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 6 years of Total Non-Current Liabilities data on file, last reported at $9.5 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 27.15% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (down 27.15% YoY) and the FY2025 annual result came in at $12.2 million, up 232.03% from the prior year.
- Total Non-Current Liabilities eased to $9.5 million in Q1 2026, from $12.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $13.1 million in Q1 2025 to a low of $3.7 million in Q4 2024.
- A 5-year average of $7.8 million and a median of $6.9 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities slumped 66.11% — and 2025, when it surged 232.65%.
- Tracing CALC's Total Non-Current Liabilities over 5 years: stood at $9.9 million in 2022, then tumbled by 59.46% to $4.0 million in 2023, then fell by 8.54% to $3.7 million in 2024, then surged by 232.03% to $12.2 million in 2025, then fell by 22.23% to $9.5 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $9.5 million (Q1 2026), $12.2 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 3.92 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 1.88 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 724.15 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.17 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 9.32 Bn |
| 10 | CalciMedica | 9.95 Mn | -8.67 Mn | - | 12.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.69 Mn |
| Mar 31, 2026 | 9.51 Mn |
| Dec 31, 2025 | 12.23 Mn |
| Sep 30, 2025 | 12.58 Mn |
| Jun 30, 2025 | 11.98 Mn |
| Mar 31, 2025 | 13.06 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 4.29 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Mar 31, 2023 | 12.65 Mn |
| Dec 31, 2022 | 9.94 Mn |
| Dec 31, 2019 | 10.09 Mn |